What are the three most important qualities in determining a startup’s success? John Halamka, MD, and Paul Cerrato of Mayo Clinic Platform address this question, and discuss the potential impact newcomers can have on the future of digital medicine.
Although the human brain has its limitations, it is capable of detecting subtle relationships among risk factors, behaviors, and disease, according to John Halamka, MD, and Paul Cerrato of Mayo Clinic Platform. When used in combination with data science and AI, “there’s no limit to what we can accomplish.”
Predicting cardiovascular disease and death is – and will always be – an imperfect science. The right AI algorithms, however, can make these estimates more accurate, according to Dr. John Halamka and Paul Cerrato of Mayo Clinic Platform.
Once considered a revolutionary way to keep patient data secure and easily accessible, blockchain continues to look for its sweet spot, according to John Halamka, MD, and Paul Cerrato of Mayo Clinic Platform. In this piece, they examine what we know the technology – and what remains unknown.
With one major milestone of the interoperability rule checked off and another approaching quickly, it’s time for leaders to “take the reins and turn these rules into actionable insights for clinicians and patients,” according to John Halamka, MD, and Paul Cerrato of Mayo Clinic Platform.